Practical Management of Patients with Atopic Dermatitis on Dupilumab
Author:
Funder
Sanofi Genzyme Canada
Publisher
Springer Science and Business Media LLC
Subject
Dermatology
Link
https://link.springer.com/content/pdf/10.1007/s13555-021-00586-w.pdf
Reference126 articles.
1. Johnson FA, Smith BJ, Bonneau M, Martin J, Romagosa C, Mazzotti F, et al. Expert elicitation, uncertainty, and the value of information in controlling invasive species. Ecol Econ. 2017;137:83–90.
2. Butler AJ, Thomas MK, Pintar KDM. Systematic review of expert elicitation methods as a tool for source attribution of enteric illness. Foodborne Pathog Dis. 2015;12:367–82.
3. Sanofi-aventis Canada Inc. Dupixent product monograph. Laval: Sanofi-aventis Canada Inc; 2017.
4. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375:2335–48.
5. Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. The Lancet. 2017;389:2287–303.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative effectiveness of treatments on time to remission in atopic dermatitis: real-world insights;Journal of Cutaneous Immunology and Allergy;2024-06-10
2. A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities;JAAD International;2024-06
3. Management of Facial Erythema on Dupilumab Treatment;Clinical Cases in Dermatology;2024
4. Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study;Dermatology and Therapy;2022-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3